Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02693314 · ClinicalTrials.gov registry record · NA
Evaluation of Jarro-Dophilus EPS® Probiotic Formulations
A NA study of Healthy, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT02693314: Completed NA study of Healthy, sponsored by University of Florida.
NCT02693314 is a NA study of Healthy that has completed, run by University of Florida. The registered enrollment target is 75 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02693314, a NA study of Healthy, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effects of the two doses of Jarro-Dophilus EPS® probiotic supplements on fecal lactobacillus and bifidobacteria numbers, transit survival of administered probiotic strains, fecal microbiota, gastrointestinal function and general wellbeing in healthy human adults.
Primary Outcome
Changes in fecal lactobacilli and bifidobacteria between treatment groups.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Jarro-Dophilus EPS® (5 billion CFU/capsule)
- DIETARY_SUPPLEMENT Jarro-Dophilus EPS® High Potency (25 billion CFU/capsule)
Study Locations (1)
Florida
- Food Science and Human Nutrition Department, University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2016-03 |
| Est. Completion | 2016-04 |
| Phase | NA |
What the finished NCT02693314 record still lists
NCT02693314 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT02693314 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02693314 about?
NCT02693314 is a clinical study titled "Evaluation of Jarro-Dophilus EPS® Probiotic Formulations". The purpose of this study is to determine the effects of the two doses of Jarro-Dophilus EPS® probiotic supplements on fecal lactobacillus and bifidobacteria numbers, transit survival of administered probiotic strains, fecal microbiota, gastrointestinal function and general wellbeing in healthy huma...
What is the current status of trial NCT02693314?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2016-03. Estimated completion is 2016-04.
What conditions does trial NCT02693314 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT02693314?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Jarro-Dophilus EPS® (5 billion CFU/capsule) (DIETARY_SUPPLEMENT), Jarro-Dophilus EPS® High Potency (25 billion CFU/capsule) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02693314?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02693314 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02693314's enrollment target sits among peer trials
75 300th of 1090 higher than 781 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia